Alcon Total Liabilities 2019-2024 | ALC
- Alcon total liabilities for the quarter ending December 31, 2024 were $8.794B, a 2.18% decline year-over-year.
- Alcon total liabilities for 2024 were $8.794B, a 2.18% decline from 2023.
- Alcon total liabilities for 2023 were $8.99B, a 5.25% decline from 2022.
- Alcon total liabilities for 2022 were $9.488B, a 8.52% increase from 2021.
Alcon Annual Total Liabilities (Millions of US $) |
|
---|---|
2024 | $8,794 |
2023 | $8,990 |
2022 | $9,488 |
2021 | $8,743 |
2020 | $8,778 |
2019 | $8,352 |
2018 | $4,423 |
Alcon Quarterly Total Liabilities (Millions of US $) |
|
---|---|
2024-12-31 | $8,794 |
2024-09-30 | $8,973 |
2024-06-30 | $8,777 |
2024-03-31 | $8,738 |
2023-12-31 | $8,990 |
2023-09-30 | $9,217 |
2023-06-30 | $9,270 |
2023-03-31 | $9,427 |
2022-12-31 | $9,488 |
2022-09-30 | $8,149 |
2022-06-30 | $8,186 |
2022-03-31 | $8,304 |
2021-12-31 | $8,743 |
2021-09-30 | $8,709 |
2021-06-30 | $8,686 |
2021-03-31 | $8,455 |
2020-12-31 | $8,778 |
2020-09-30 | $8,758 |
2020-06-30 | $8,708 |
2020-03-31 | $8,028 |
2019-12-31 | $8,352 |
2019-09-30 | $8,248 |
2019-06-30 | $8,322 |
2019-03-31 | $0 |
2018-12-31 | |
2018-09-30 | $0 |
2018-06-30 | $0 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | MED INSTRUMENTS | $48.486B | $9.911B |
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. |